
Neuro Resource Group (NRG) specializes in the development, design and manufacture of innovative medical products for injury management, rehabilitation, and pain management. The Company's management team has extensive experience in the healthcare industry and is committed to providing products that both improve the quality of patients' lives and enhance athletes' performance in sport.
|

|
Sean Browne
Chief Executive Officer
Browne is the former President of Miltex Surgical Instruments, a division of Integra LifeSciences of Plainsboro, NJ, a leading provider of surgical instruments to the alternate site marketplace. Browne replaces David O. Turner, who was serving as interim CEO following the retirement of NRG founder Tommy Thompson.
Prior to joining Miltex, Browne served as Vice President of Sales and Marketing and was the first non-founder senior manager at Esurg Corporation, a provider of medical supplies, pharmaceutical supplies and office supplies for physicians' offices. Prior to Esurg, Mr. Browne served as the Sr. Vice President of the Health Systems division of McKesson Healthcare's Pharmaceutical division. Prior to McKesson, Browne served nine years with Baxter Healthcare in a number of capacities.
Browne received his Bachelor of Science degree from Boston University, majoring in Finance. In 1996, he received his Masters of Management from Northwestern's Kellogg School of Management with a concentration in Strategy and Marketing.
|
|
|
David O. Turner
Chief Operating Officer
Dave Turner is a senior executive with extensive experience in high-tech electronics and medical device manufacturing. In his 25 years at Texas Instruments, Turner held management positions in the areas of defense electronics, missiles, electro-optics, radar, and consumer electronics.
At Quest Medical (now Advanced Neuromodulation Systems, Inc.), Turner was Chief Operating Officer for four years, where he led the development and launch of their Cardioplegia Delivery System and Neurostimulation product lines - both successful medical devices.
Turner is experienced in bringing advanced technology to market and has international experience in Europe and the Far East. He has a Bachelor of Science degree in Engineering Physics from the University of Illinois and an MBA from Southern Methodist University.
|
|
|
Thomas C. Thompson
Retired founder, President and CEO
Tommy Thompson is a successful and recognized leader in the medical device industry. His 30 years as a President and CEO has included 5 years as a Division President for Baxter Healthcare, and 18 years with Quest Medical (now Advanced Neuromodulation Systems, Inc.) of which he was a founder. Thompson brings to NRG a wealth of experience that has included private funding, strategic alliances and three public offerings.
Thompson has co-founded two companies that manufactured products for intravenous drug delivery, cardiovascular surgery, and implantable neurostimulation. In the US, Thompson was co-founder and founding chairman of the Medical Device Manufacturing Association, which played a key role in the legislative reform of the FDA in 1997 and the reform of Group Purchasing Organization practices in 2002. With his roots in electronic engineering, Thompson has also been responsible for major development programs in microprocessor-based instrumentation and sterile, disposable medical devices. Thompson received his B.S.E.E. from the University of Texas.
|
|
|
Zulia Frost, MD
Senior Vice President, Medical Director
Zulia Frost, M.D. graduated as a Doctor of General Medicine and Pediatrics from the State Medical Institute, Almaty, Kazakhstan. Following her internship at a children's hospital, Frost worked in a specialist Emergency Aid hospital before completing post-graduate training in ultrasonic diagnostics and radiology.
After practicing medicine for 10 years, Frost relocated to the UK. In 1999, whilst living in the UK, she discovered a new type of neurostimulation technology that was developed in Russia and later became known as Interactive Neurostimulation technology. Impressed by the results she achieved with patients, Frost began researching this advanced technology and has since become recognized as the leading clinician and trainer.
Frost's pioneering work in the field of Interactive Neurostimulation therapy led to her joining the team at NRG to realize the vision of this advanced technology becoming a standard of care in medicine throughout the world.
|
|
|
|
Guy P. Beckerlegge
Senior Vice President, Special Accounts
Guy Beckerlegge received a Bachelor of Science Degree in Economics and Politics with honors from the University of Plymouth in Devon, England. He then worked as a shipbroker in London. After realizing his interest was in helping people regain their health, Beckerlegge studied for four years and received a degree in Chinese Medicine. He then became a licensed acupuncturist and is a member of the British Board of Acupuncturists.
After developing and running two successful health clinics, Beckerlegge was introduced to Interactive Neurostimulation therapy, and incorporated it into his practice. Beckerlegge's success treating patients with the technology led him to team up with Dr. Zulia Frost to promote the use of Interactive Neurostimulation on a worldwide basis. Along with Dr. Frost, Beckerlegge joined NRG at its inception.
|
|
|
James E. Stringer
Vice President East Coast Region, US
James Stringer has over 20 years of professional sales and marketing experience in information technology, within both the manufacturing and distribution sectors. Before NRG, Stringer was Vice President of Sales for Comstor, the leading distributor of Cisco networking products in Europe.
Positive Energy, a training and consultancy company founded by Stringer, was hired by Comstor in 1997 to build their Cisco training division, and its successful launch led to him joining the Board of Directors. Following an acquisition by Datatec, Comstor became part of the New York based Westcon Group. Stringer and his team continued to over-achieve their $75 million quarterly sales targets to win awards as the top performing subsidiary within the group.
Stringer was introduced to Interactive Neurostimulation therapy in early 2003 during treatment for a back problem with Dr. Zulia Frost. He became fascinated with the technology and its potential, working with Dr. Frost and Guy Beckerlegge before moving to the US to become part of the team at NRG.
|
|
|
Paul Magee
VP, Clinical Training & Education
Paul Magee received a Bachelor of Arts degree in German and Economics at Derby University before moving on to study and qualify in Sports Therapy. Paul spent his first 2 years working in a Physiotherapy department promoting the physical activity and wellbeing of adults with learning disabilities, organizing and implementing hydrotherapy, rebound therapy and exercise sessions for the hospital residents. He then set up his own Sports Therapy clinic dealing with sports and work related injuries using his expertise in manual therapy, biomechanical analysis and InterX technology to offer a fast and effective solution for musculoskeletal problems. Paul experienced "phenomenal and inexplicable results on some very severe pain conditions" which prompted him to leave his clinic and devote all his time to InterX. His experience as a former customer of NRG has helped him extensively in his role as Director of Training and Development, researching many of the technical aspects of InterX to support a greater understanding and knowledge for users of the technology.
|
|
|
Krista R. Oakes
Vice President, Quality and Regulatory Affairs
Krista Oakes has nearly two decades of experience in medical device quality assurance, regulatory affairs, and executive management, including former experience as Director of Regulatory Affairs for Quest Medical, Inc. Senior level experience includes positions as Vice President of RA/QA (and later President) of Epic Medical, Inc., and Vice President, Medical Device Division, in the regulatory consulting firm of Shotwell and Carr, Inc. Her experience includes successful US 510(k) premarket notifications, CE marking and other international licenses/approvals, and “business-friendly” quality systems designed to meet both FDA and international requirements, for a broad range of medical devices, including many electronic and software-driven medical devices.
Krista is an active industry participant, serving as a member and former co-chair of the Dallas District FDA/Industry Medical Device Coalition (FMDIC), and as a regulatory advisor to the North Texas Enterprise Center for Medical Technology (NTEC). Krista has been an industry speaker and author on the topic of practical and efficient approaches to regulatory compliance. She has received industry certifications as a Quality Auditor, Quality Manager, and an ISO Lead Assessor, and holds a B.S. degree in psychology from Brigham Young University.
|
|